Bolar Begins Drug Recall: Bolar Pharmaceutical Co....

Bolar Begins Drug Recall: Bolar Pharmaceutical Co. voluntarily began the recall of a generic antibiotic used to treat urinary tract infections a day after the federal Food and Drug Administration requested the action. The FDA contends that Bolar cheated on product safety tests when it submitted the drug, nitrofurantoin, for FDA approval. Bolar, which is the largest of the generic drug makers under FDA scrutiny, won approval for its generic version of nitrofurantoin in June 1988.